Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Current and Projected Market Size of the Single-Chamber Prefilled Syringes Market Through 2034?
In recent times, there has been a significant increase in the market size of single-chamber prefilled syringes. The market, which was valued at $10.72 billion in 2024, is projected to expand to $11.97 billion in 2025 with a compound annual growth rate (CAGR) of 11.6%. The historic surge can be credited to factors such as expansion within the pharmaceutical and biotechnology sectors, user-friendly drug administration methods, demand for accurate drug dosage, ease and safety of use, regulatory approval, and guidelines.
The market size for single-chamber prefilled syringes is anticipated to witness swift expansion in the coming years, skyrocketing to $22.05 billion in 2029 with a compound annual growth rate (CAGR) of 16.5%. This escalation during the future period can be ascribed to various factors like the presence of biologics and biosimilars in prefilled syringes, the rise of self-administration and home healthcare, an increased focus on pediatric and geriatric drug delivery, combination products with auto-injectors, regulatory focus on drug safety, as well as advances in telemedicine and remote monitoring. Key trends identified for the forecast period involve prefilled syringes associated with connected devices, use of sustainable and biodegradable materials, provision for personalized syringe alternatives, prevention of needlestick accidents and safety features, application of prefilled syringes for cell and gene therapies, and introduction of prefilled syringes equipped with anti-counterfeit provisions.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5419&type=smp
Which Primay Drivers Are Accelerating Growth in the Single-Chamber Prefilled Syringes Market?
The escalation of chronic conditions like diabetes and cancer is propelling the growth of the single-chamber prefilled syringe market. This type of syringe is particularly utilized by diabetes patients who necessitate insulin treatment when their blood glucose levels are not managed by medication. For instance, the World Health Organization, a Swiss-based authority on global public health, foresees an increase of 77%, resulting in over 35 million new cancer cases by 2050, up from an expected 20 million cases in 2022. Consequently, this rise in chronic conditions such as diabetes and cancer is a driving force behind the expanding market for single-chamber prefilled syringes.
Which Primary Segments of the Single-Chamber Prefilled Syringes Market Are Driving Growth and Industry Transformations?
The single-chamber prefilled syringesmarket covered in this report is segmented –
1) By Type: Glass, Plastic
2) By Application: Vaccine Product, Biologic, Pharmaceutical Product
Subsegments:
1) By Glass: Borosilicate Glass Syringes, Type I Glass Syringes, Type II Glass Syringes
2) By Plastic: Polypropylene Syringes, Polycarbonate Syringes, Cyclo-olefin Polymer Syringes
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=5419&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Single-Chamber Prefilled Syringes Market?# Market?
North America was the largest region in the single-chamber prefilled syringes market in 2024. Asia-Pacific was the second largest region in the single-chamber prefilled syringes market share. The regions covered in the single-chamber prefilled syringes market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Which Technological Trends Are Reshaping the Single-Chamber Prefilled Syringes Industry Dynamics?
The single-chamber prefilled syringe market is undergoing transformation due to advancements in technology. Firms in this sector are concentrating their efforts on creating innovative technological solutions to solidify their foothold in the market. For example, in September 2022, a novel product named Aripiprazole 2-month was released by Otsuka America Pharmaceutical, Inc., a healthcare company based in the US, and H. Lundbeck A/S, an international pharmaceutical firm from Denmark. The product is a single-chamber, prefilled syringe with a long-acting, injectable form of aripiprazole that lasts two months. The injection is to be administered intramuscularly in the gluteal muscle every two months, as per the recommended dosage.
View the full report here:
What Parameters Are Used to Define the Single-Chamber Prefilled Syringes Market?
Single-chamber prefilled syringes refer to syringes that come pre-filled with a specific dose of medication in a single compartment. These syringes are designed for easy, precise administration, reducing the risk of dosing errors and improving convenience for both healthcare providers and patients.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5419
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model